晖致制药（大连）有限公司
- Country
- Ownership
- -
- Established
- 1989-10-07
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
28
NMPA:28
Drug Approvals
Atorvastatin Calcium Tablets
- Product Name
- 立普妥
- Approval Number
- 国药准字H20051407
- Approval Date
- May 12, 2020
NMPA
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 舒普深
- Approval Number
- 国药准字H20020598
- Approval Date
- May 12, 2020
NMPA
Cefoperazone Sodium for Injection
- Product Name
- 注射用头孢哌酮钠
- Approval Number
- 国药准字H19994141
- Approval Date
- May 12, 2020
NMPA
Atorvastatin Calcium Tablets
- Product Name
- 立普妥
- Approval Number
- 国药准字H20051409
- Approval Date
- May 12, 2020
NMPA
Benproperine Phosphate Tablets
- Product Name
- 磷酸苯丙哌林片
- Approval Number
- 国药准字H21023264
- Approval Date
- May 12, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found